Serum sickness and severe angioedema following rituximab therapy in RA

Int J Rheum Dis. 2012 Feb;15(1):e6-7. doi: 10.1111/j.1756-185X.2011.01645.x. Epub 2011 Aug 31.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Angioedema / chemically induced*
  • Angioedema / diagnosis
  • Angioedema / drug therapy
  • Antibodies, Monoclonal, Murine-Derived / adverse effects*
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / diagnosis
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Glucocorticoids / therapeutic use
  • Histamine H1 Antagonists, Non-Sedating / therapeutic use
  • Humans
  • Middle Aged
  • Rituximab
  • Serum Sickness / chemically induced*
  • Serum Sickness / diagnosis
  • Serum Sickness / drug therapy
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Glucocorticoids
  • Histamine H1 Antagonists, Non-Sedating
  • Rituximab